Janus Henderson Group
RCUS icon

Janus Henderson Group’s Arcus Biosciences RCUS Stock Holding History

Janus Henderson Group’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$916K Hold
42,338
– – ﹤0.01% 1736
2025
Q4 		$1.01M Buy
42,338
+11,300
+36% +$231K ﹤0.01% 1669
2025
Q3 		$423K Hold
31,038
– – ﹤0.01% 2066
2025
Q2 		$253K Hold
31,038
– – ﹤0.01% 2243
2025
Q1 		$254K Buy
31,038
+13,000
+72% +$151K ﹤0.01% 2279
2024
Q4 		$268K Hold
18,038
– – ﹤0.01% 2301
2024
Q3 		$276K Hold
18,038
– – ﹤0.01% 2303
2024
Q2 		$274K Sell
18,038
-218
-1% -$3.52K ﹤0.01% 2246
2024
Q1 		$345K Sell
18,256
-30
-0.2% -$519 ﹤0.01% 2174
2023
Q4 		$349K Sell
18,286
-35
-0.2% -$559 ﹤0.01% 2160
2023
Q3 		$329K Buy
18,321
+4
+0% +$80 ﹤0.01% 2144
2023
Q2 		$372K Sell
18,317
-24
-0.1% -$457 ﹤0.01% 2138
2023
Q1 		$334K Buy
+18,341
New +$351K ﹤0.01% 2229
2022
Q4 		– Sell
-8,002
Closed -$209K – 2492
2022
Q3 		$209K Sell
8,002
-94
-1% -$2.49K ﹤0.01% 2388
2022
Q2 		$205K Buy
8,096
+122
+2% +$2.99K ﹤0.01% 2291
2022
Q1 		$252K Sell
7,974
-7
-0.1% -$235 ﹤0.01% 2322
2021
Q4 		$323K Buy
+7,981
New +$310K ﹤0.01% 2167
2020
Q1 		– Sell
-296,000
Closed -$2.99M – 1399
2019
Q4 		$2.99M Sell
296,000
-204,654
-41% -$1.72M ﹤0.01% 1123
2019
Q3 		$4.56M Sell
500,654
-6,875
-1% -$55.2K ﹤0.01% 1068
2019
Q2 		$4.04M Buy
507,529
+681
+0.1% +$6.82K ﹤0.01% 1076
2019
Q1 		$6.33M Sell
506,848
-391
-0.1% -$4.24K ﹤0.01% 970
2018
Q4 		$5.46M Buy
507,239
+36,937
+8% +$431K ﹤0.01% 959
2018
Q3 		$6.56M Buy
470,302
+787
+0.2% +$10K ﹤0.01% 988
2018
Q2 		$5.75M Buy
469,515
+928
+0.2% +$14.6K ﹤0.01% 1005
2018
Q1 		$7.24M Buy
+468,587
New +$7.81M ﹤0.01% 952

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Janus Henderson Group's RCUS Position: Q1 2026 in Review

Janus Henderson Group held its Arcus Biosciences (RCUS) position steady in Q1 2026 at 42,338 shares worth $916K. The position accounts for ﹤0.01% of the portfolio, ranked #1736.

Janus Henderson Group first reported a position in RCUS in Q1 2018 and has held it in 25 quarters since. The position peaked at $7.24M in Q1 2018. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

  • Janus Henderson Group held 42,338 shares of Arcus Biosciences worth $916K as of Q1 2026.
  • Janus Henderson Group left its Arcus Biosciences share count unchanged in Q1 2026.
  • Arcus Biosciences made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #1736 holding.
  • Janus Henderson Group first reported a position in Arcus Biosciences in Q1 2018 and has held it in 25 quarters since.
  • Janus Henderson Group's Arcus Biosciences position peaked at $7.24M in Q1 2018.
  • 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.